Ioana Rus

Iuliu Hațieganu University of Medicine and Pharmacy — Romania

Medicine · Health Sciences

7h-index255citations32works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(8), Acute Lymphoblastic Leukemia research(5), Chronic Lymphocytic Leukemia Research(5), Chronic Myeloid Leukemia Treatments(5), Acute Myeloid Leukemia Research(4)

Publications32 total

CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases
Blood Reviews·2025Open Access
Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myeloma
Biomarker Research·2025· 2 citedOpen Access
894 | REAL LIFE EXPERIENCE WITH SILTUXIMAB IN CASTLEMAN DISEASE
Hematological Oncology·2025Open Access
883 | SILTUXIMAB IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: REAL‐WORLD EXPERIENCE FROM ROMANIA AND GREECE
Hematological Oncology·2025Open Access
Real world outcomes with Ibrutinib monotherapy in chronic lymphocytic leukemia: a single center experience
Medicine and Pharmacy Reports·2025Open Access
Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World Experience
Journal of Hematology·2024· 5 citedOpen Access
<scp>RNA</scp> methylation sequencing shows different gene expression signatures for response to azacytidine therapy in high‐grade myelodysplastic syndromes
Journal of Cellular and Molecular Medicine·2024· 1 citedOpen Access
Preclinical Evaluation of an Anti-CD41 CAR T Cell in Acute Megakaryoblastic Leukemia on in Vitro and In Vivo Models
Transplantation and Cellular Therapy·2024
Blood transfusions in non-major burns patients
Burns·2023· 4 cited
Design and preclinical testing of an <scp>anti‐CD41 CAR</scp> T cell for the treatment of acute megakaryoblastic leukaemia
Journal of Cellular and Molecular Medicine·2023· 5 citedOpen Access
A Survival Analysis of Acute Myeloid Leukemia Patients Treated With Intensive Chemotherapy: A Single Center Experience
Cureus·2023· 4 citedOpen Access
Flow Cytometry of CD5-Positive Hairy Cell Leukemia
Molecular Diagnosis & Therapy·2023· 3 cited
COVID-19 Impact on Chronic Myeloid Leukemia Patients
Journal of Personalized Medicine·2022· 7 citedOpen Access
Mechanistic Insights in Hemophagocytic Lymphohistiocytosis: Subsequent Acute Hepatic Failure in a Multiple Myeloma Patient Following Therapy with Ixazomib-Lenalidomide-Dexamethasone
Journal of Personalized Medicine·2022· 4 citedOpen Access
Current therapeutic approaches in the management of hemophilia—a consensus view by the Romanian Society of Hematology
Annals of Translational Medicine·2021· 17 citedOpen Access
A narrative review of central nervous system involvement in acute leukemias
Annals of Translational Medicine·2021· 71 citedOpen Access
Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies
Journal of Clinical Medicine·2020· 3 citedOpen Access
Complete metabolic remission in an 84-year old patient with relapsed/refractory diffuse large B-cell lymphoma following combination immunotherapy with lenalidomide plus rituximab
International Journal of Hematology·2020· 1 cited
Paraneoplastic hypereosinophilia in a patient with peripheral T cell lymphoma, not otherwise specified
Medicine and Pharmacy Reports·2019· 7 citedOpen Access
Persistent Basophilia May Suggest an “Accelerated Phase” in the Evolution of CALR-Positive Primary Myelofibrosis Toward Acute Myeloid Leukemia
Frontiers in Oncology·2019· 20 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Ciprian Tomuleasa(22), Delia Dima(19), Mihnea Zdrenghea(15), Bobe Petrushev(12), Patric Teodorescu(9), Cătălin Constantinescu(9), Alina Tănase(9), Sergiu Paşca(8), Anca Bojan(8), Adrian Bogdan Țigu(8), Sabina Iluta(7), Ciprian Jitaru(7), Diana Cenariu(7), Raluca Munteanu(6), Cristina Selicean(6), Bogdan Fetică(6), Dávid Kegyes(6), Anamaria Bancos(6), A. Gal(6), C. Cătoi(6)